Literature DB >> 23036962

PEG modified BaGdF₅:Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging.

Songjun Zeng1, Ming-Kiu Tsang, Chi-Fai Chan, Ka-Leung Wong, Jianhua Hao.   

Abstract

Herein, a multi-functional nanoprobe of polyethylene glycol (PEG) modified BaGdF₅:Yb/Er upconversion nanoparticles (UCNPs) for tri-modal bioimaging of fluorescence, computed X-ray tomography (CT), and magnetic application is demonstrated for the first time. The PEG-modified BaGdF₅:Yb/Er UCNPs with optimal small size were synthesized by a facile one-pot hydrothermal method. The as-designed single-phase nanoprobe presents near-infrared to visible upconversion emissions in UC fluorescent bioimaging of HeLa cell. Importantly, we have demonstrated in vivo CT images with enhanced signals of spleen of a mouse for 2 h, indicating the UCNPs can be successfully used as CT contrast agent for improving the detection of splenic diseases. In addition, these UCNPs also exhibit excellent intrinsic paramagnetic property which can be also for magnetic imaging. Therefore, our results indicate that a tri-modal nanoprobe served as fluorescent/CT/magnetic bioimaging can be realized using the PEG-modified BaGdF₅:Yb/Er UCNPs with very low cytotoxicity and long circulation time, which would be very useful in a variety of biomedical application fields.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036962     DOI: 10.1016/j.biomaterials.2012.09.019

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  18 in total

1.  Upconversion Nanoparticle-Mediated Optogenetics.

Authors:  Zhigao Yi; Angelo H All; Xiaogang Liu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Authors:  James Rieffel; Upendra Chitgupi; Jonathan F Lovell
Journal:  Small       Date:  2015-07-16       Impact factor: 13.281

3.  Rare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics.

Authors:  Dominik J Naczynski; Mei Chee Tan; Richard E Riman; Prabhas V Moghe
Journal:  J Mater Chem B       Date:  2014-05-28       Impact factor: 6.331

4.  Europium-phenolic network coated BaGdF5 nanocomposites for tri-modal computed tomography/magnetic resonance/luminescence imaging.

Authors:  Wei Zhu; Shuang Liang; Jing Wang; Zhe Yang; Li Zhang; Tianmeng Yuan; Zushun Xu; Haibo Xu; Penghui Li
Journal:  J Mater Sci Mater Med       Date:  2017-03-30       Impact factor: 3.896

Review 5.  Targeted nanotechnology for cancer imaging.

Authors:  Randall Toy; Lisa Bauer; Christopher Hoimes; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2014-08-09       Impact factor: 15.470

Review 6.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

Review 7.  Implications of Biomolecular Corona for Molecular Imaging.

Authors:  Morteza Mahmoudi; Anna Moore
Journal:  Mol Imaging Biol       Date:  2020-10-23       Impact factor: 3.484

8.  Time-dependent density functional theory calculations of the solvatochromism of some azo sulfonamide fluorochromes.

Authors:  Przemysław Krawczyk
Journal:  J Mol Model       Date:  2015-04-16       Impact factor: 1.810

Review 9.  Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents.

Authors:  Derong Zhu; Fuyao Liu; Lina Ma; Dianjun Liu; Zhenxin Wang
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

10.  NaGdF4:Eu3+ Nanoparticles for Enhanced X-ray Excited Optical Imaging.

Authors:  L Sudheendra; Gautom K Das; Changqing Li; Daniel Stark; Jake Cena; Simon Cherry; Ian M Kennedy
Journal:  Chem Mater       Date:  2014-02-17       Impact factor: 9.811

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.